Bárbara Bellini

ORCID: 0000-0003-0187-065X
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Cardiac Valve Diseases and Treatments
  • Coronary Interventions and Diagnostics
  • Infective Endocarditis Diagnosis and Management
  • Cardiac Imaging and Diagnostics
  • Aortic Disease and Treatment Approaches
  • Acute Myocardial Infarction Research
  • Cardiovascular Function and Risk Factors
  • Peripheral Artery Disease Management
  • Cardiac Structural Anomalies and Repair
  • Vascular Procedures and Complications
  • Cardiac pacing and defibrillation studies
  • Cardiac, Anesthesia and Surgical Outcomes
  • Cerebrovascular and Carotid Artery Diseases
  • Acute Kidney Injury Research
  • Cardiac Arrhythmias and Treatments
  • Atrial Fibrillation Management and Outcomes
  • Cardiac and Coronary Surgery Techniques
  • Cardiovascular and Diving-Related Complications
  • Liver Disease and Transplantation
  • Central Venous Catheters and Hemodialysis
  • Renal and Vascular Pathologies
  • Liver Disease Diagnosis and Treatment
  • Pericarditis and Cardiac Tamponade
  • Kawasaki Disease and Coronary Complications
  • IoT and Edge/Fog Computing

Vita-Salute San Raffaele University
2013-2025

Istituti di Ricovero e Cura a Carattere Scientifico
2018-2025

Istituto di Ricovero e Cura a Carattere Scientifico San Raffaele
2019-2025

San Raffaele University of Rome
2016-2024

IRCCS Ospedale San Raffaele
2022-2024

Universidade do Vale do Rio dos Sinos
2021-2024

Society of Interventional Radiology
2020-2023

October 6 University
2023

Ospedale Maggiore
2022

Hospital Universitario Reina Sofía
2016

oronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), is causing a dramatic pandemic. 1ombardy, in northern Italy, one of the most affected regions worldwide. 2ardiovascular complications occur frequently patients with COVID-19, 3 challenges management.We aimed to evaluate incidence, clinical presentation, angiographic findings, and outcomes ST-elevation myocardial infarction (STEMI) COVID-19.All hospitals catherization laboratories...

10.1161/circulationaha.120.047525 article EN mit Circulation 2020-04-30

In the prevention of variceal rebleeding, it is already established that hemodynamic response to drug treatment (decrease in hepatic venous pressure gradient [HVPG] 12 mm Hg or by >20%) predictive clinical effectiveness. primary prophylaxis very few data are available. We assessed role beta–blockers plus nitrates predicting efficacy prophylaxis. A total 49 cirrhotic patients with varices at risk bleeding, without prior were investigated vein catheterization before and after 1 3 months...

10.1053/jhep.2000.19322 article EN Hepatology 2000-11-01

The aim of this study was to describe the epidemiology, mechanisms, management, and outcomes coronary artery perforation during chronic total occlusion (CTO) percutaneous intervention (PCI).We included 1,811 consecutive patients undergoing CTO PCI at five centres between 2011 2018. Coronary observed in n=99 (5.5%). Patients with were older, had a higher J-CTO score, more often required antegrade dissection/re-entry retrograde approach, lower success rates. frequency Ellis type I, II, III...

10.4244/eij-d-19-00282 article EN EuroIntervention 2019-10-01

The aim of the present study was to compare midterm clinical outcomes patients undergoing successful chronic total occlusion (CTO) percutaneous coronary intervention (PCI) according crossing technique used, in a large multicentre registry.We compiled registry consecutive CTO PCI. Patients were divided into three groups: true-to-true (TTT) approach, modern dissection/re-entry (DR) techniques (CrossBoss/Stingray, reverse CART), and old DR (LAST, STAR, CART). Cox regression used identify...

10.4244/eij-d-16-01010 article EN EuroIntervention 2017-10-01

Objectives . To study the long‐term outcomes of rotational atherectomy (RA) for chronic total occlusion (CTO) percutaneous coronary intervention (PCI). Background There is little evidence on incidence, procedural results and RA CTO PCI. Methods This registry included data from consecutive patients undergoing PCI at four specialized centers. Major adverse cardiac events (MACE: death, target‐vessel myocardial infarction ischemia‐driven revascularization) follow‐up were primary endpoint....

10.1002/ccd.26829 article EN Catheterization and Cardiovascular Interventions 2016-12-28

A significant number of patients with non-valvular atrial fibrillation (NVAF) are ineligible for non-vitamin K oral anticoagulants (NOACs) due to previous major bleeding or because they at high risk (HBR). In this setting the indication percutaneous left appendage closure (LAAO) is a valuable alternative. We aimed evaluate efficacy and safety NOACs versus LAAO in NVAF HBR (HAS-BLED ≥3).All consecutive who underwent successful (n=193) those treated (n=189) (dabigatran, apixaban rivaroxaban)...

10.4244/eij-d-19-00507 article EN EuroIntervention 2020-04-01

BACKGROUND: The anatomic and physiological changes associated with severe aortic stenosis may influence the functional evaluation of coronary stenoses. In this study, we aimed to assess in resting hyperemic indices before immediately after transcatheter valve implantation (TAVI) their relationship microvascular resistance. METHODS: pooled analysis 3 prospective observational studies, fractional flow reserve (FFR), full-cycle ratio (RFR), Pd/Pa were measured patients TAVI left anterior...

10.1161/circinterventions.124.014940 article EN Circulation Cardiovascular Interventions 2025-04-11
Coming Soon ...